Whites tend to have higher rates of success in HCV treatment compared to minorities. However, there should be no hope lost as "DAAs hold promise in closing the SVR gap between different race/ethnicity groups."
Whites tend to have higher rates of success in HCV treatment compared to minorities. However, there should be no hope lost as "DAAs hold promise in closing the SVR gap between different race/ethnicity groups."